Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo

Equine Veterinary Journal

Volumn 41, Issue 7, 2009, Pages 717-719

  Nieto, J E ^a   MacDonald, M H ^a   Poulin Braim, A E ^b   Aleman, M ^c  

^a Departments of Surgical and Radiological Sciences   (United States)

^b VM: Medicine and Epidemiology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Endotoxin; Equine; Gene expression; Horse; Lipopolysaccharide

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HORSE; MALE; METABOLISM;

ANIMALS; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORSES; LIPOPOLYSACCHARIDES; MALE;

BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 70349211633     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516409X464780     Document Type: Article

References (15)

1. Allen, C.A., Payne, S.L., Harville, M., Cohen, N. and Russell, K.E. (2007) Validation of quantitative polymerase chain reaction assays for measuring cytokine expression in equine macrophages. J. Immunol. Methods. 328, 59-69.
2. An, N., Song, Y., Zhang, X., Ci, X., Li, H., Cao, Y., Zhang, M., Cui, J. and Deng, X. (2008) Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines. Immunopharmacol. Immunotoxicol. 30, 437-446.
3. Barton, M.H. and Collatos, C. (1999) Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J. vet. intern. Med. 13, 457-464.
4. Baskett, A., Barton, M.H., Norton, N., Anders, B. and Moore, J.N. (1997) Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am. J. vet. Res. 58, 1291-1299.
5. DeLa Cadena, R.A., Majluf-Cruz, A., Stadnicki, A., Agosti, J.M., Colman, R.W. and Suffredini, A.F. (1996) Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profile. Immunopharmacol. 33, 231-237.
6. Dinarello, C.A. (1988) Interleukin-1. Dig. Dis. Sci. 33, 25S-35S.
7. Dinarello, C.A. (2004) Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin. Res. 10, 201-222.
8. Herzum, I. and Renz, H. (2008) Inflammatory markers in SIRS, sepsis and septic shock. Curr. Med. Chem. 15, 581-587.
9. Kuhns, D.B., Alvord, W.G. and Gallin, J.I. (1995) Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J. Infect. Dis. 171, 145-152.
10. Moore, J.N., Norton, N., Barton, M.H., Hurley, D.J., Reber, A.J., Donovan, D.C., Vandenplas, M.L., Parker, T.S. and Levine, D.M. (2007) Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine vet. J. 39, 243-248.
11. Morris, D.D., Moore, J.N. and Crowe, N. (1991) Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am. J. vet. Res. 52, 1565-1569.
12. Opal, S.M. and Yu, R.L., Jr. (1998) Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions. Drugs 55, 497-508.
13. Salgado, A., Boveda, J.L., Monasterio, J., Segura, R.M., Mourelle, M., Gomez- Jimenez, J. and Peracaula, R. (1994) Inflammatory mediators and their influence on haemostasis. Haemostasis 24, 132-138.
14. Steverink, P.J., Salden, H.J., Sturk, A., Klein, W.R., van der Velden, M.A. and Nemeth, F. (1994) Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders. Vet. Q. 16, Suppl. 2, S117-121.
15. Werners, A.H., Bull, S. and Fink-Gremmels, J. (2005) Endotoxaemia: a review with implications for the horse. Equine vet. J. 37, 371-383.